Standout Papers

The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adu... 2023 2026 202483
  1. The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials (2023)
    Brandon Essink, Laurence Chu et al. The Lancet Infectious Diseases

Immediate Impact

1 by Nobel laureates 54 standout
Sub-graph 1 of 23

Citing Papers

Skin preparation–free, stretchable microneedle adhesive patches for reliable electrophysiological sensing and exoskeleton robot control
2024 Standout
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
1 intermediate paper

Works of Steven Wang being referenced

The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials
2023 Standout
Nanotechnology in Dermatology
2012

Author Peers

Author Last Decade Papers Cites
Steven Wang 132 46 42 150 68 23 524
Hsiu‐Li Lin 132 53 103 129 94 32 533
Tokinari Abe 138 119 24 145 85 36 577
Yusuf Gedik 69 37 54 80 90 47 582
Orhun Çamurdan 153 24 70 107 113 32 538
de Man 86 55 64 55 97 34 605
Michael Dalton 86 46 27 66 52 23 462
Shaye Kivity 55 81 31 63 150 25 537
Nigel W. Brown 107 13 75 124 50 25 543
Elinor M. Zorn 138 24 51 38 103 24 594
C.F. Hawkins 69 40 7 56 40 18 545

All Works

Loading papers...

Rankless by CCL
2026